<DOC>
	<DOCNO>NCT02674412</DOCNO>
	<brief_summary>This study evaluate utility buspirone patient diagnosis functional dysphagia . All participant randomize receive either placebo pill buspirone . Subsequently , evaluate whether swallow improve . Participants randomize receive placebo receive buspirone receive buspirone receive placebo . We evaluate whether swallow improve .</brief_summary>
	<brief_title>Buspirone Functional Dysphagia</brief_title>
	<detailed_description>Buspirone help modulate molecule affect activity muscle esophagus . Studies past show healthy people , buspirone improve vigor esophagus squeeze propel food stomach . In patient functional dysphagia , esophagus muscle may weak ( defined manometry ) . Our two phase study evaluate symptom difficulty swallow vigor esophagus propels bolus patient 1 ) receive placebo pill 2 ) receive buspirone pill . We hypothesize placebo pill affect vigor muscle symptoms difficulty swallowing , buspirone improve outcome .</detailed_description>
	<mesh_term>Deglutition Disorders</mesh_term>
	<mesh_term>Buspirone</mesh_term>
	<criteria>Diagnosis IEM per Chicago Classification , v3.0 criterion note Esophagogastroduodenosocopy ( EGD ) negative mechanical obstruction Esophageal biopsy negative eosinophilic esophagitis Pregnant woman Prisoners Currently serotonin modulate medication</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>